Literature DB >> 18804416

Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.

Kevin Damman1, Dirk J van Veldhuisen, Gerjan Navis, Adriaan A Voors, Hans L Hillege.   

Abstract

Renal impairment, as measured by reduced glomerular filtration rate (GFR) and increased urinary albumin excretion (UAE), is prevalent in patients with chronic heart failure (CHF) and is associated with reduced survival. The prevalence of structural tubular damage in CHF is unknown. We investigated 90 CHF patients and 20 age and sex matched healthy controls, and determined estimated GFR, UAE, N terminal-pro brain natriuretic peptide (NT-proBNP) and urinary neutrophil gelatinase associated lipocalin (NGAL) as a marker for tubular damage. CHF patients had significantly lower averaged estimated GFR (64+/-17 vs 90+/-12 mL/min/1.73 m(2), P<0.0001), but higher NT-proBNP and UAE levels (both P<0.0001). Median urinary NGAL levels were markedly increased in CHF patients compared to controls (175 (70-346) vs 37 (6-58) microg/gCr, P<0.0001). Both serum creatinine (r=0.26, P=0.006) and eGFR (r=-0.29, P=0.002) were significantly associated with urinary NGAL levels as were NT-proBNP and UAE but to a lesser extent. In conclusion, renal impairment in CHF patients is not only characterised by decreased eGFR and increased UAE, but also by the presence of tubular damage, as measured by increased urinary NGAL concentrations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804416     DOI: 10.1016/j.ejheart.2008.07.001

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  62 in total

Review 1.  Glutamate synthase: a fascinating pathway from L-glutamine to L-glutamate.

Authors:  R H H van den Heuvel; B Curti; M A Vanoni; A Mattevi
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

Review 2.  Cardiac biomarkers: new tools for heart failure management.

Authors:  Navaid Iqbal; Bailey Wentworth; Rajiv Choudhary; Alejandro De La Parra Landa; Benjamin Kipper; Arrash Fard; Alan S Maisel
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

3.  Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure.

Authors:  Frederik H Verbrugge; Matthias Dupont; Zhili Shao; Kevin Shrestha; Dhssraj Singh; Michael Finucan; Wilfried Mullens; W H Wilson Tang
Journal:  J Card Fail       Date:  2013-09       Impact factor: 5.712

Review 4.  Perspective on Clinical Application of Biomarkers in AKI.

Authors:  Chirag R Parikh; Sherry G Mansour
Journal:  J Am Soc Nephrol       Date:  2017-02-20       Impact factor: 10.121

5.  Renal biomarkers for the initiation of renal replacement therapy-is this the future?

Authors:  Melanie Meersch; Alexander Zarbock; Mira Küllmar
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

6.  Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.

Authors:  Lori B Daniels; Elizabeth Barrett-Connor; Paul Clopton; Gail A Laughlin; Joachim H Ix; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2012-03-20       Impact factor: 24.094

7.  Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events.

Authors:  Sean P Collins; Kimberly W Hart; Christopher J Lindsell; Gregory J Fermann; Neal L Weintraub; Karen F Miller; Susan N Roll; Matthew I Sperling; Douglas B Sawyer; Alan B Storrow
Journal:  Eur J Heart Fail       Date:  2012-06-25       Impact factor: 15.534

Review 8.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

9.  Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.

Authors:  Yalcin Solak; Mahmut Ilker Yilmaz; Dimitrie Siriopol; Mutlu Saglam; Hilmi Umut Unal; Halil Yaman; Mahmut Gok; Hakki Cetinkaya; Abduzhappar Gaipov; Tayfun Eyileten; Sebahattin Sari; Ali Osman Yildirim; Halil Zeki Tonbul; Suleyman Turk; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-10-26       Impact factor: 2.370

10.  Heart-kidney biomarkers in patients undergoing cardiac stress testing.

Authors:  Mikko Haapio; Andrew A House; Massimo de Cal; Dinna N Cruz; Paolo Lentini; Davide Giavarina; Antonio Fortunato; Luigi Menghetti; Matteo Salgarello; Andrea Lupi; Giuliano Soffiati; Alessandro Fontanelli; Pierluigi Zanco; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.